Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)

Clinical trial NCT04697810 · UNKNOWN

Trial details

NCT number: NCT04697810
Sponsor: Can-Fite BioPharma
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

NASH - Nonalcoholic Steatohepatitis

Start date: 2021-12-10
Primary completion: 2025-04-15
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.